Brief: Heron Therapeutics Announces the Inclusion of ZYNRELEF as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy

Heron Therapeutics

15/07/2024 13:25

July 15 (Reuters) - Heron Therapeutics Inc  HRTX.O :
    * HERON THERAPEUTICS ANNOUNCES THE INCLUSION OF ZYNRELEF® AS
A
QUALIFYING PRODUCT UNDER THE PROPOSED 2025 NON-OPIOID POLICY FOR
PAIN RELIEF UNDER THE OPPS AND THE ASC PAYMENT SYSTEM

Source text for Eikon:  ID:nPnb9k7rca 
Further company coverage:  HRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))